Fall 2023 - Spring 2024 Grand Rounds

Time: Thursdays, 12:00 PM–1:00 PM
Location: Yawkey 4820
Course Director: Colin D. Weekes, MD, PhD

The Mass General Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research. This year’s theme for the series is Women in Cancer.

Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters.

Outside of Mass General and interested in viewing the Grand Rounds? Click here to access our new Mass General Cancer Center Grand Rounds subscription available to the public.

View past presentations.


Spring 2024 Grand Rounds Schedule

January 4, 2024
ASH Update

Classical Heme (Jonathan Carlson, MD, PhD)
Leukemia (Rupa Narayan, MD)
Lymphoma (Jacob Soumerai, MD)
Myeloma (Diana Cirstea, MD)
BMT (Richard Newcomb, MD)
Cell Therapy (Mark Leick, MD)

January 11, 2024
Integrating Clinical and Laboratory Research to Identify Mechanisms of Response and Resistance to Immune Checkpoint Therapy

Padmanee Sharma, MD, PhD
MD Anderson Cancer Center

January 18, 2024
From the Ether Dome to Seldin Plaza: My Path in Renal Cell Carcinoma

Tian Zhang, MD
UT Southwestern Medical Center

January 25, 2024
Can’t Stop, Won’t Stop: The Development of New Therapies, and New Trialists, Toward a Future of Cure

Janice Mehnert, MD
NYU Langone Health

February 1, 2024
From Trailblazers to Leaders: Role of Women As Division Chiefs

S. Gail Eckhardt, MD, FASCO
Baylor College of Medicine

Merry Markham, MD, FACP, FASCP
University of Florida Health

February 8, 2024
Advocacy in Oncology: Connecting What Matters with Our Science and Care

Pamela Kunz, MD
Yale School of Medicine

February 29, 2024
Brain Metastases of Breast Cancer

Patricia Steeg, PhD
National Institutes of Health

March 7, 2024
Gastric Cancer Program: Innovations and Advances

Vivian Strong, MD, FACS
Memorial Sloan Kettering Cancer Center

March 14, 2024
Rethinking Radiation Oncology Using HPV Driven Oropharyngeal Carcinoma as a Model

Nancy Lee, MD, FASTRO
Memorial Sloan Kettering Cancer Center

March 21, 2024
Bridging the GAP While Shattering Ceilings

Rachna Shroff, MD, MS, FASCO
University of Arizona Cancer Center

March 28, 2024
Talk Title TBD

Rebecca Karp, MD
Massachusetts General Hospital

Amy Dickey, MD, MSc
Massachusetts General Hospital

April 4, 2024
DEI as a Competitive Advantage

Clifton David Fuller, MD, PhD
MD Anderson Cancer Center

April 11, 2024
Talk Title TBD

Marco Ruella, MD
University of Pennsylvania

April 25, 2024
Talk Title TBD

Courtney DiNardo, MD, MSCE
MD Anderson Cancer Center

May 2, 2024
ACS-IRG Scholars

Speakers TBD

May 9, 2024
Talk Title TBD

Max Diehn, MD, PhD
Stanford University

May 16, 2024
State of Cancer

Elizabeth Jaffee, MD
Johns Hopkins Medicine

May 23, 2024
Clinical Pathologic Conference

Speakers TBD

Fall 2023 Grand Rounds Schedule

September 7, 2023
The Chabner Pioneers in Oncology Lectureship – Precision Medicine for Primary and Metastatic Brain Tumors: From Bench to Bedside (and Back to Bench)

Priscilla Brastianos, MD
Mass General Cancer Center

September 21, 2023
Junior Scientist Lectures

Targeted Approaches to Treatment of Pleural Mesothelioma: Are We There Yet?

Ibiayi Dagogo-Jack, MD
Mass General Cancer Center

Gut Bacteria Illuminate a Mechanistic Strategy for Cancer Immunotherapy

Francesca Gazzaniga, PhD
Massachusetts General Hospital

September 28, 2023
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Cancer

Cigall Kadoch, PhD
Dana-Farber Cancer Institute

October 5, 2023
Novel Therapeutics in Gynecologic Cancers

Roisin O’Cearbhaill, MD
Memorial Sloan-Kettering Cancer Center

October 12, 2023
Women in Cancer: Navigating the Glass Ceiling

Lisa Butterfield, PhD
University of California San Francisco

Kornelia Polyak, MD, PhD
Dana-Farber Cancer Institute

Noopur Raje, MD
Mass General Cancer Center

October 26, 2023
Lippard Lecture: Defining and Exploiting Tumor-Host Interactions

Christina Curtis, PhD, MSc
Stanford University

November 9, 2023
Achieving Success as A Square Peg in the Round Hole of Academic Medicine

Jennifer Temel, MD
Mass General Cancer Center

November 30, 2023
Female Participant Engagement in Cancer Research: Sample Programs from the Field to a Pandemic

Lourdes Baezconde-Garbanati, PhD
University of Southern California

December 7, 2023
The Dobbs Decision: Implications for Women’s Health and Cancer Care

Lisa Barroilhet, MD
University of Wisconsin School of Medicine and Public Health

December 14, 2023
Targeted Therapy for Premenopausal Early Breast Cancer: A 100 Year Old Strategy

Sandra Swain, MD
Georgetown University Medical Center

 

Previous Grand Rounds

Spring 2023

January 5, 2023
ASH Update

Anem Waheed, MD, MPH
Mass General Cancer Center

Matthew Frigault, MD
Mass General Cancer Center

Yi-Bin Chen, MD
Mass General Cancer Center

Amir Fathi, MD
Mass General Cancer Center

Andrew Yee, MD
Mass General Cancer Center

January 12, 2023
Learning the Rules of Human Tumor Immunity

Nir Hacohen, PhD
Director, MGH Center for Cancer Immunotherapy
Center for Cancer Research
Professor of Medicine, Harvard Medical School
Senior Member, Broad Institute

January 19, 2023
Junior Scientist Lecture

Evaluating Novel Cancer Therapeutic Strategies Using Living Tumor Biopsies
Russell Jenkins, MD, PhD
Principal Investigator, Mass General Research Institute
Assistant in Medicine, Mass General Cancer Center
Assistant Professor, Harvard Medical School

Programming T Cell Exhaustion: Lessons from Chronic Viral Infection
Debattama Sen, MD
Principal Investigator
Mass General Cancer Center Center for Cancer Research
Assistant Professor, Harvard Medical School

January 26, 2023
Improving Response to Immune Checkpoint Inhibitor Therapy Through Solving the Underpinnings of Immune-Related Adverse Events

A. Chloe Villani, PhD
Assistant Investigator, Center for Immunology and Inflammatory Diseases
Mass General Cancer Center Center for Cancer Research
Assistant Professor, Harvard Medical School

February 2, 2023
2022 Assembly Award Winner Lecture: Targeting TBK1 to Overcome Resistance to Cancer Immunotherapy

Russell Jenkins, MD, PhD
Principal Investigator, Mass General Research Institute
Assistant in Medicine, Mass General Cancer Center
Assistant Professor, Harvard Medical School

February 9, 2023
Tissue-Based Immune Profiling and Pan-Tumor Pathologic Response Signatures

Janice Taube, MD, MSc
Director, Division of Dermatopathology
Professor of Dermatology
Johns Hopkins Medicine

February 16, 2023
Clinical Pathologic Conference: A 57-Year-Old Woman with Melanoma and Fever

Jiyoon Kang, DO
Massachusetts General Hospital

Matthew Meizlish, MD, PhD
Massachusetts General Hospital

Amir Mohareb, MD
Massachusetts General Hospital

Kam Montazeri, MD
Mass General Cancer Center

Stuti Shroff, MBBS, PhD
Massachusetts General Hospital

March 2, 2023
Cell Cycle Checkpoint Defects as Targets for Cancer Therapy: From Bench to Bedside

Kelly Hunt, MD, FACS, FSSO
Professor and Chair, Department of Breast Surgical Oncology
MD Anderson Cancer Center

March 16, 2023
Genetics, Immunobiology and Targeted Therapy of Hodgkin Lymphoma

Margaret Shipp, MD
Douglas S. Miller Chair in Lymphoma
Director, DF/HCC Lymphoma Research Program
Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School

March 30, 2023
Immunotherapy for the Treatment of Acute Leukemias: Fake News?

John DiPersio, MD, PhD
Virginia E. and Sam J. Golman Professor in Medicine
Director, Center for Gene and Cellular Immunotherapy
Washington University School of Medicine in St. Louis

April 6, 2023
Progress in Immunotherapy for Breast Cancer

Leisha Emens, MD, PhD
Senior Vice President, Translational Research
Ankyra Therapeutics

April 20, 2023
Creating a Culture of Inclusion

Karen Winkfield, MD, PhD
Executive Director, Meharry Vanderbilt Alliance
Ingram Professor of Cancer Research
Professor of Radiology Oncology, VUMC
Professor of Medicine, Meharry Medical College

April 27, 2023
Neoadjuvant Immunotherapy for Resectable Lung Cancer

Patrick Forde, MBBCh
Co-Director, Division of Upper Aerodigestive Malignancies
Director, Thoracic Oncology Research Program
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University

May 4, 2023
Cancer Immunotherapy, Shared Immune Escape and the Age of Engineering

Daniel Chen, MD, PhD
Founder, Engenuity Life Sciences

May 11, 2023
Normalizing the Tumor Microenvironment to Improve Immunotherapy of Cancer: Emerging Insights and Strategies

Rakesh Jain, PhD
Director, Steele Laboratory
Massachusetts General Hospital
A. Werk Cook Professor of Radiation Oncology
Harvard Medical School

May 18, 2023
CPC: A 45 Year-Old Female with Metastatic Triple-Negative Breast Cancer

Baris Boyraz, MD, PhD
Massachusetts General Hospital

Kevin Oh, MD
Massachusetts General Hospital

Karen Rodriguez, MD
Massachusetts General Hospital

Neelima Vidula, MD
Mass General Cancer Center

Alexandra Wong, MD
Massachusetts General Hospital

May 25, 2023
A Regulator’s Perspective on Endpoints Supporting Immuno-Oncology Approvals

Marc Theoret, MD
Deputy Director
Oncology Center of Excellence
U.S. Food and Drug Administration

Fall 2022

September 15, 2022
Leveraging Opportunities to Facilitate Inclusive Cancer Drug Development

Lola Fashoyin-Aje, MD, MPH
Deputy Division Director
Associate Director, Science & Policy to Address Disparities
Oncology Center of Excellence
FDA

September 22, 2022
ACS-IRG Scholar Presentations

The MGH Catch Project: Improving Community Access to Colon Cancer Screening
Adjoa Anyane-Yeboa, MD, MPH
Massachusetts General Hospital

An Omics Approach to Drug Discovery
Liron Bar-Peled, PhD
Mass General Cancer Center

CAR Talk: What Clinicians Say and Patients Understand about Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Tejaswini Dhawale, MD
Mass General Cancer Center

Spatial Transcriptomics of HCC Reveals Distinct Vascular Neighborhoods
Joseph Franses, MD, PhD
Mass General Cancer Center

Intermediate States in Pancreatic Cancer Tumorigenesis Inferred by Single-Nucleus RNA-Sequencing
William Hwang, MD, PhD
Massachusetts General Hospital

September 29, 2022
Lymphocytes as a “Living Drug” for the Treatment of Cancer

Steven A. Rosenberg, MD, PhD
Chief, Surgery Branch
National Cancer Institute

October 6, 2022
Extending Immunotherapy Combinations in Gastroesophageal Cancer: How, What and When?

Ian Chau, MD, FRCP
Department of Medicine
Royal Marsden Hospital

October 13, 2022
New Considerations for Immunotherapy in Sarcoma

Seth M. Pollack, MD
Director of the Sarcoma Program, Lurie Cancer Center
Steven T. Rosen Professor of Cancer Biology
Associate Professor, Department of Medicine (Hematology and Oncology)
Northwestern University Feinberg School of Medicine

October 27, 2022
Kidney Cancer: Bench to Bedside and Back

James Brugarolas, MD, PhD
Director, Kidney Cancer Program
UT Southwestern

November 3, 2022
Debate: Adjuvant/Neoadjuvant Immune Checkpoint Inhibitor Therapy

Rodabe Amaria, MD
Associate Professor, Department of Melanoma Medical Oncology
Director of Melanoma Clinical Research and Early Drug Development
The University of Texas MD Anderson Cancer Center

Jeffrey Weber, MD, PhD
Deputy Director
Laura and Isaac Perlmutter Cancer Center
Professor of Medicine
NYU School of Medicine

Paul Chapman, MD
Attending Physician
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Medical College and Graduate School of Medical Sciences of Cornell University

November 10, 2022
TLR9 Agonists in Melanoma and Other Cancers: Current Development, Next Steps

Diwakar Davar, MD
Assistant Professor of Medicine
Medical Oncologist/Hematologist
UPMC

November 17, 2022
Lippard Lecture: Heterogeneity of Breast Cancer Across Diverse Populations

Olufunmilayo Olopade, MD, FACP
Walter L. Palmer Distinguished Service Professor of Medicine
Professor of Human Genetics
Director, Center for Clinical Cancer Genetics and Global Health
UChicago Medicine

December 1, 2022
The Chabner Pioneers in Oncology Lectureship: Translating Aging Biology Into Patient Care

Norman Sharpless, MD
Former Director, NCI

December 15, 2022
Immune Related Adverse Events: Discussion of Mechanisms and Models for Discovery

Arlene Sharpe, MD, PhD
George Fabyan Professor of Comparative Pathology
Chair, Department of Immunology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School

Stephen Elledge, PhD
Gregor Mendel Professor of Genetics
Department of Genetics, Harvard Medical School
Division of Genetics, Brigham & Women’s Hospital

Spring 2022

January 6, 2022
ASH Update

Rupa Narayan, MD
Mass General Cancer Center

Connor Johnson, MD
Mass General Cancer Center

Anem Waheed, MD
Mass General Cancer Center

Matt Frigault, MD
Mass General Cancer Center

Andrew Yee, MD
Mass General Cancer Center

January 13, 2022
Junior Scientist Lecture

Looking Beyond the Marker: Pharmacologic and Immunotherapeutic Targeting of MUC16 (CA-125) Positive Gynecologic Cancers
Oladapo Yeku, MD
Mass General Cancer Center

Epidemiology and Prognostic Implications of Cutaneous Immunotherapy Toxicities
Eugene Semenov, MD
Massachusetts General Hospital

January 20, 2022
Confronting Inequity in Modern Therapy for Rare Melanomas

Alexander Shoushtari, MD
Memorial Sloan Kettering Cancer Center

January 27, 2022
Advancing Therapies for Children and Adults with Rare Solid Tumors or Genetic Tumor Predisposition Syndromes

Brigitte Widemann, MD
National Institutes of Health

February 3, 2022
2021 Assembly Award Winners and Lectureship

Safety and Immunogenicity of SARS-CoV2 Vaccines in Patients with Cancer
Justin Gainor, MD
Mass General Cancer Center

Clinical Resistance to KRAS Inhibition
Ryan Corcoran, MD, PhD
Mass General Cancer Center

February 10, 2022
Turning on Apoptotic Switch in Leukemia: BCL-2 and Beyond

Amir Fathi, MD
Mass General Cancer Center

Marina Konopleva, MD
MD Anderson Cancer Center

February 17, 2022
Clinical Pathologic Conference: A 66-Year-Old Man with Progressive Dyspnea and Neck Swelling, and a Lung Mass

Jennifer Temel MD – Medical Oncology
Katie Keane, MD - Radiation Oncology
David Dudzinski, MD - Cardiology
Subba Digumarthy, MD - Radiology
Colleen Keyes, MD - Pulmonary
Daniel Shepherd, MD - Pathology
Massachusetts General Hospital

March 3, 2022
Leadership Toolbox for Faculty Development Strategies to Enhance Diversity within the Profession

Charles Thomas, Jr., MD
Dartmouth-Hitchcock Norris Cotton Cancer Center

March 10, 2022
Engineering CAR-T Cells: Combating Tumor Resistance and Relapse

Renier Brentjens, MD, PhD
Roswell Park Comprehensive Cancer Center

March 17, 2022
Informing Race/Ethnicity Modeling for Colorectal Cancer Screening

John Carethers, MD
University of Michigan

March 24, 2022
The Race Between Immunity and Ovarian Cancer: How Tryptophan Metabolism Shapes the Outcome

Adekunle Odunsi, MD, PhD
University of Chicago

March 31, 2022
Senior Fellows Lecture

Interrogating the Immunogenicity of SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia
Erika Haydu, MD, PhD
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute

Improving Outcomes for Hospitalized Patients with Advanced Cancer
Daniel Lage, MD, MSc
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute

Decoding the Rules of Pancreatic Cancer Plasticity and Immune Regulations
Arnav Mehta, MD, PhD
Fellow in Hematology/Oncology
Mass General Cancer Center / Dana-Farber Cancer Institute

April 14, 2022
Personalizing Care for Older Adults with Cancer

Heidi Klepin, MD
Wake Forest School of Medicine

April 21, 2022
Oncologic Anthropology: Role of Genomics and Genetics in Correlating African Ancestry with High-Risk/Triple Negative Breast Cancer

Lisa Newman, MD, MPH
Weill Cornell Medicine

April 28, 2022
The Business of Cell Therapies for Cancer

James Economou, MD, PhD
University of California Los Angeles

May 5, 2022
The Mid-South Miracle: A Program-Based Implementation Project to Eliminate Geographic Lung Cancer Disparities

Raymond Osarogiagbon, MD
Baptist Cancer Center

May 12, 2022
ACS IRG Scholars

Raj Gopal, MD, PhD
Massachusetts General Hospital

Daniel Hall, PhD
Massachusetts General Hospital

Andrew Liss, PhD
Massachusetts General Hospital

Erica Shenoy, MD, PhD
Massachusetts General Hospital

Eric Wehrenberg-Klee, MD
Massachusetts General Hospital

May 19, 2022
Clinical Pathologic Conference: A 22-Year-Old Female with Abdominal Pain

Baris Boyraz, MD, PhD
Massachusetts General Hospital

Sophia Kamran, MD
Massachusetts General Hospital

Allison Kimball, MD
Massachusetts General Hospital

Philip Saylor, MD
Mass General Cancer Center

Madeleine Sertic, MBBCH, BAO
Massachusetts General Hospital

Fall 2021

September 23, 2021
Industry Roundtable: A Conversation About Cancer Equity

Ruma Bhagat, MPH
Senior Science Leader Global Health Equity Strategy
Genentech, Inc.

Patrice Matchaba, MD
Global Head of Corporate Responsibility
Novartis US

Coleman Obasaju, MD, PhD
Senior Medical Director - Oncology
Eli Lilly and Company

David Windsor
Clinical Trials Diversity Ops Lead for Oncology
Pfizer

September 30, 2021
Keynote Address: The Impact of Population and Tumor Heterogeneity in Cancer Genome Science

John D. Carpten, PhD
Professor and Chair of Translational Genomics
Director, Institute of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Department of Translational Genomics
Keck School of Medicine of USC

October 7, 2021
DNA Damage Repair Deficient Pancreas Cancer

Talia Golan, MD
Head of Sheba Pancreatic Cancer Center
Sheba Medical Center, Tel HaShomer

October 14, 2021
Clinical Pathologic Conference: A 29-Year-Old Woman with Jaundice and Chronic Diarrhea

Jon Dubois, MD
Medical Oncologist
Mass General Cancer Center

Jennifer Wo, MD
Radiation Oncology
Massachusetts General Hospital

Avinash Kambadakone, MD
Radiology
Massachusetts General Hospital

M. Lisa Zhang, MD
Pathology
Massachusetts General Hospital

October 21, 2021
Utilizing Underlying Tumor Biology to Guide Immunotherapy Drug Development in Sarcoma, One Subtype at a Time

Sandra D’Angelo, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center

October 28, 2021
Patient-Centered Care in the Precision Oncology Era

Laura Petrillo, MD
Palliative Medicine
Mass General Cancer Center

November 4, 2021
The Chabner Pioneers in Oncology Lectureship: Getting to the Root of Cancer Health Disparities: A Journey to Health Equity

Michele K. Evans, MD
Deputy Scientific Director & Chief
Health Disparities Research Section
National Institute on Aging
National Institutes of Health

November 11, 2021
Immune-Related Toxicities: Diversity in Clinical Research and Innovation

Jarushka Naidoo, MB, BCH, MHS
Assistant Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Bloomberg-Kimmel Institute for Cancer Immunotherapy

November 18, 2021
Lippard Lecture: Endometrial Cancer: Genetic Models & Translational Studies

Diego Castrillon, MD, PhD
Professor
Vernie A. Stembridge, MD, Distinguished Chair in Pathology
UT Southwestern Medical Center

December 2, 2021
Hot Topic Debate: Is Disease-Free Survival an Acceptable Surrogate Endpoint for Emerging Adjuvant TKI/IO Studies in NSCLC?

Justin Gainor, MD
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital

Rebecca Heist, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital

Zofia Piotrowska, MD
Assistant Professor, Medicine
Harvard Medical School
Assistant in Medicine, Medicine
Massachusetts General Hospital

December 9, 2021
Disrupting the Paradigm in Cancer Research: Bringing the Patient into the P-Value

Jill Feldman
Group Founder, EGFR Resisters

Spring 2021

January 7, 2021
ASH Update

Sharl Azar, MD
Jeffrey Barnes, MD, PhD
Andrew Brunner, MD
Thomas Spitzer, MD
Andrew Yee, MD
Mass General Cancer Center

January 14, 2021
Cancer Therapeutics and Diagnostics: A View from My Lens

David Schenkein, MD
General Partner, Google Ventures
Adjunct Professor of Medicine, Hematology and Oncology
Tufts Medical Center

January 21, 2021
Unraveling Immune Checkpoint Inhibitor Toxicities

Douglas B. Johnson, MD, MCSI
Assistant Professor of Medicine, Clinical Director, Melanoma
Vanderbilt- Ingram Cancer Center
Vanderbilt University

January 28, 2021
A Functional Genomics Platform for Precision Medicine

Jeffrey W. Tyner, PhD
Professor of Medicine
Department of Cell, Development and Cancer Biology
Oregon Health and Sciences University

February 4, 2021
MGH American Cancer Society Institutional Research Grant (IRG) Awardee Presentations

Deborah Forst, MD
Mass General Cancer Center

Rachel Jimenez, MD
Massachusetts General Hospital

Christine Chiasson MacKenzie, PhD
Mass General Cancer Center

February 11, 2021
Refining Disease States in Response to PD-1 Blockade

Matthew D. Hellman, MD
Lung Cancer, Immunotherapy, Clinical Trials
Associate Attending, Hematology/Oncology
Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center

February 18, 2021
CPC: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia

Richard Newcomb, MD
Dana-Farber Cancer Institute

Andrew Crabbe, MD, PhD
Massachusetts General Hospital

Andrew Brunner, MD
Mass General Cancer Center

Yi-Bin Chen, MD
Mass General Cancer Center

March 4, 2021
New Findings in Endocrine Therapy of Breast Cancer

Nancy Davidson, MD
Senior Vice President, Director and Professor
Clinical Research Division, Fred Hutch
Raisbeck Endowed Chair for Collaborative Research
Fred Hutch
President and Executive Director, Seattle Cancer Care Alliance

March 11, 2021
Understanding Responses to Cancer Therapy: The Tissue is the Issue, the Scoop is in the Poop, and You are What You Eat

Jennifer Wargo, MD
MD Anderson Cancer Center

March 18, 2021
Molecular Profiling of Gliomas: Secrets Revealed

Arnab Chakravarti, MD
Chair and Professor, Department of Radiation Oncology
Klotz Family Chair of Cancer Research
Director, Brain Tumor Program
Ohio State University Comprehensive Cancer Center and Richard L. Solove Research Institute
Arthur G. James Cancer Hospital
The Ohio State University Medical School

March 25, 2021
Late Recurrences in Estrogen Receptor Breast Cancer

Daniel F. Hayes, MD, FASCO, FACP
Stuart B. Padnos Professor of Breast Cancer Research
University of Michigan Rogel Cancer Center

April 1, 2021
Debate: Discussion of Incorporation of Radiation Therapy into Management of Localized Pancreas Adenocarcinoma

Ted Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology
Associate Clinical Director, Department of Radiation Oncology
Massachusetts General Hospital

Wells Messersmith, MD
Professor, Medicine-Medical Oncology
University of Colorado Anschutz Medical Campus

April 8, 2021
Immunotherapy of Small Cell Lung Cancer: What is Next?

Taofeek Owonikoko, MD, PhD
Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine

April 15, 2021
Junior Faculty Lecture: Regulatory Drivers in Cancers

Esther Rheinbay, PhD
Assistant Professor of Medicine
Mass General Cancer Center

Liron Bar-Peled, PhD
Assistant Professor, Medicine
Harvard Medical School
Investigator, Center for Cancer Research
Massachusetts General Hospital

April 22, 2021
Looking Beyond Scopes, Scans, and Smears: The Future of Cancer Screening

Sana Raoof, MD, PhD
Medical Resident
Massachusetts General Hospital

April 29, 2021
Development of Epigenetic Therapy in GI Malignancies

Nita Ahuja, MD, MBA, FACS
William H. Carmalt Professor of Surgery
Chair, Department of Surgery
Interim Director, Yale Cancer Center
Interim Physician-in-Chief, Smilow Cancer Hospital

Nilo Azad, MD
Associate Professor of Oncology
Johns Hopkins University

May 6, 2021
State of Cancer in America: 2021

Clifford A. Hudis, MD
CEO, American Society of Clinical Oncology

May 13, 2021
Next Gen Immunotherapy Strategies in Prostate Cancer: Can Immunocytokines Succeed Where PD1/PDL1 Inhibitors Have Not?

Ravi A. Madan, MD
Clinical Director, Genitourinary Malignancies Branch
National Institutes of Health

May 20, 2021
CPC: A 25-Year-Old Man with Visual Changes, Thrombocytopenia, and B Cell-ALL

Zack DeFilipp, MD
Dept. of Medicine, MGH

Annabelle Anandappa, MD
Dept. of Medicine, MGH

Karen Rodriguez, MD
Dept. of Radiology, MGH

Judith Ferry, MD
Dept. of Pathology, MGH

May 27, 2021
Oncolytic Immunovirotherapy against Glioma: From the Bench to the Clinic and Back

Evanthia Galanis, MD
Medical Oncologist, Brain Tumor Program
Mayo Clinic

Fall 2020

September 17, 2020
The Chabner Pioneers in Oncology Lectureship: Lung Cancer Therapy

Paul Bunn, MD
Medicine-Medical Oncology
James Dudley Chair in Cancer Research
Professor, Lung Cancer
University of Colorado Hospital

September 24, 2020
COVID Response: Lessons Learned from the COVID Surge at MGH and What to Expect for the Future

Kerry Reynolds, MD
Clinical Director, Inpatient Oncology Units
Director, Severe Immunotherapy Complications Program
Mass General Cancer Center

Paul Biddinger, MD
Chief, Division of Emergency Preparedness
Director, MGH Center for Disaster Medicine

Anne Prestipino, MPH
Senior Vice President of Strategy and Clinical Operations
Mass General Cancer Center

October 1, 2020
COVID Response: Using Registries to Inform Risk Assessment and Care Delivery for Individuals with Cancer During the COVID-19 Pandemic

William Wood, MD
Associate Professor of Medicine, Division of Hematology
UNC School of Medicine

October 8, 2020
COVID Response: Temporal and Spatial Heterogeneity of SARS-CoV-2 Pulmonary Infection

David Ting, MD
Assistant Physician, Hematology/Oncology
Mass General Cancer Center

October 15, 2020
21st-Century Impact of Cancer Care

Robert Winn, MD
Director
Senior Associate Dean for Cancer Innovation
VCU School of Medicine

October 22, 2020
Me Biased? Unconscious Bias in Medicine and Medical Education

Narjust Duma, MD
Hematology/Oncology Faculty
Department of Medicine
School of Medicine and Public Health
University of Wisconsin

October 29, 2020
Clinical Pathologic Conference: 34-Year-Old Woman with Abdominal Distension, Fatigue, and Acute Kidney Insufficiency

Sundar Jagannath, MD
Mount Sinai Hospital, NYC

Mark Anderson, MD
Department of Radiology
Massachusetts General Hospital

Andrew Yee, MD
Mass General Cancer Center

Robert Hasserjian, MD
Department of Pathology
Massachusetts General Hospital

November 5, 2020
How Many Myelomas Are There?

Nikhil Munshi, MD
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute

November 12, 2020
Heparin-Induced Thrombocytopenia: Still with us. Still a problem.

Douglas Cines, MD
Professor of Medicine, Professor of Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine
Director, Coagulation Laboratory

November 19, 2020
Lippard Lecture

Diego Castrillon, MD
Vernie A. Stembridge, M.D., Distinguished Chair in Pathology
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center

December 3, 2020
Chief Fellows Lecture

Chi-Joan How, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute

Connor Johnson, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute

Chris Nabel, MD
Medical Oncology Fellow
Mass General Cancer Center

December 10, 2020
Debate: Time to De-Escalate Treatment in Oropharyngeal Carcinoma?

Moderator:
Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Mass General Cancer Center

Panelists:
Barbara Burtness, MD
Professor of Medicine
Disease Aligned Research Team Leader, Head and Neck Cancers Program
Co-Leader, Developmental Therapeutics
Yale Cancer Center

Annie Chan, MD
Director, Head and Neck Radiation Oncology Research Program
Massachusetts General Hospital

John Clark, MD
Clinical Director, Center for Head and Neck Cancers
Mass General Cancer Center

Jeremy Richmon, MD
Director, Head and Neck Robotic Surgery
Massachusetts Eye and Ear